omega-n-methylarginine has been researched along with amlodipine in 5 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (amlodipine) | Trials (amlodipine) | Recent Studies (post-2010) (amlodipine) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 4,200 | 1,504 | 1,671 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | amlodipine (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | 1.2 | |
| Potassium channel subfamily K member 2 | Homo sapiens (human) | 0.4 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.602 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.8 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 2.898 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 5.521 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 2.7 | |
| Potassium channel subfamily K member 2 | Bos taurus (cattle) | 0.43 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, N; Lyons, D; Webster, J | 1 |
| Higashi, Y; Kajiyama, G; Matsuura, H; Nakagawa, K; Oshima, T; Sasaki, S | 1 |
| Kim, CH; Lee, MM; Oh, BH; On, YK; Park, YB | 1 |
| Choi, YS; Kim, CH; Lee, MM; Oh, BH; On, YK; Park, YB; Sohn, DW | 1 |
| Bartels, H; Berkels, R; Breitenbach, T; Klaus, W; Roesen, R; Taubert, D | 1 |
3 trial(s) available for omega-n-methylarginine and amlodipine
| Article | Year |
|---|---|
The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension.
Topics: Amlodipine; Arginine; Blood Pressure; Double-Blind Method; Enalapril; Female; Forearm; Humans; Hypertension; Male; Middle Aged; omega-N-Methylarginine; Regional Blood Flow | 1994 |
Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Calcium Channel Blockers; Enalapril; Endothelium, Vascular; Female; Forearm; Humans; Hypertension; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow | 2002 |
Improvement of endothelial function by amlodipine and vitamin C in essential hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Ascorbic Acid; Calcium Channel Blockers; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Vasodilation | 2002 |
2 other study(ies) available for omega-n-methylarginine and amlodipine
| Article | Year |
|---|---|
Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Endothelium, Vascular; Female; Forearm; Humans; Hyperemia; Hypertension; Imidazoles; Imidazolidines; Male; Middle Aged; omega-N-Methylarginine; Regional Blood Flow; Vascular Resistance; Vasodilation | 2001 |
Amlodipine increases endothelial nitric oxide by dual mechanisms.
Topics: Amlodipine; Animals; Antioxidants; Aorta; Cells, Cultured; Coronary Vessels; Cyclic GMP; Endothelial Cells; Endothelium, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; omega-N-Methylarginine; Reactive Oxygen Species; Superoxides; Swine; Up-Regulation; Xanthine Oxidase | 2004 |